PTC Therapeutics Receives Positive CHMP Opinion for Upstaza™ for the Treatment of AADC Deficiency

/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Upstaza™ (eladocagene exuparvovec; PTC-AADC) received a positive opinion from the...

Related Keywords

Liechtenstein ,Norway ,National Taiwan University Hospital ,T Ai Pei ,Taiwan ,Iceland ,United States ,Jeanine Clemente ,Kylie Okeefe ,Stuartw Peltz ,Liang Hwu ,Instagram ,Linkedin ,Twitter ,European Commission ,Administration Of Upstaza ,Nasdaq ,Lancet Child Adolesc Health ,Child Neurology Society ,Therapeutics Inc ,European Union ,European Medicines Agency ,Facebook ,Committee For Medicinal Products Human Use ,Medicinal Products ,Human Use ,Chief Executive Officer ,Paul Wuh Liang Hwu ,Lead Investigator ,National Taiwan University ,More Information ,Private Securities Litigation Reform Act ,Annual Report ,Annual Meeting ,Child Adolesc ,Ptc Therapeutics ,Nc ,